Anavex Life Sciences Corp (AVXL)

[Gator328]

There are 2 ways to read your question:

1. Will AVXL be selling Blarcamesine within 6 months, as in will the drug be available on the open market?

2. Will AVXL be selling Blarcamesine within 6 months, as in will the company license or sell the rights?

I think you were referencing #2, but the answer to both is most likely "no." I expect at this point Dr. Missling is confident enough to submit to the FDA without a partner, and if approved maximize the leverage he has entering negotiation. At worst, he'll be told to run another confirmatory P3 trial -- and he has the cash to do so with minimal dilution. More likely, he'll be asked to run a P4 trial -- and with the LPC deal he'll have the cash to continue advancing the rest of the pipeline.